Bernstein lifts Virbac to 'outperform', as Supercharge portfolio boosts margins

By Reuters News

** Bernstein upgrades French veterinary products maker Virbac VIRB.PA to "outperform", saying first-half results provide evidence that its "Supercharge" portfolio is becoming a meaningful driver of margin expansion

** Broker highlights robust and broad-based sales momentum across regions, with Europe up 6.5%, international sales up 7.5% and North America delivering 10% organic growth in H1 despite Q2 manufacturing disruption

** It flags that company's FY26 guidance has evolved toward the upper end of the 5.5%-7.5% organic growth range, with the EBIT margin target maintained at around 17%

** Bernstein raises EPS estimates by 6% to 11% for 2026-2029 and its PT to €426 ($489.01), implying 35% upside from the current price

** Out of 10 analysts that cover the company, seven rate the stock "strong buy" or "buy,"​ and two rate "hold" — LSEG data

($1 = 0.8712 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.